Catello Somma is a Partner at Seroba. He has a background in venture capital and clinical development, with a focus on the biotechnology and medical device industries.

Catello graduated in 2007 summa cum laude from the University of Naples Federico II and in 2014 completed an MBA at POLIMI Graduate School of Management.

Prior to joining the firm in 2024, Catello was at TVM Capital (Munich), involved across different strategies for both biotech and medtech. Before starting a career in venture capital, Catello co-founded a Boston VC-baked biotech start-up (exited), developing therapeutics for oncology and autoimmune diseases. He started his career in 2009 working for different CROs and biotech companies between Italy and Switzerland. Through his previous roles within clinical and corporate development, he is actively contributing with his expertise to driving and supporting new and existing investments across funds and thesis.